BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2007
View Archived Issues
Human papillomavirus vaccine 16/18 shows promise in phase III trial
Read More
Pharmacological activity of DZ-697b investigated in vitro
Read More
KDN-7438: a novel TF/FVIIa inhibitor with anticoagulant activity in vivo
Read More
Adenosine A2A agonism decreases acute inflammation and improves posthemorrhagic vasospasm in rats
Read More
Adenosine A2A antagonism has no effect on dopamine depletion-induced deficits in cognition
Read More
Epeius' targeted gene delivery system Rexin-G enters advanced phase I/II trials
Read More
Cell Genesys completes enrollment of phase III study of GVAX immunotherapy
Read More
Catalyst begins phase II trial of CPP-109 for cocaine dependence
Read More
Recent patents disclose new agents for respiratory and allergic disorders
Read More
Recent patents describe new treatment options for endocrine-related disorders
Read More
Novel therapeutic agents for obesity and lipoprotein disorders described in recent patents
Read More
J-30: a novel microtubule-disrupting agent with antitumor efficacy in vivo
Read More
Novel HDAC inhibitor described by CrystalGenomics
Read More
Fludara tablet launched in Japan
Read More
OT-551 holds promise for oncology and inflammatory conditions
Read More
Ziopharm reports positive interm data for phase II trial of ZIO-201
Read More
Critical Therapeutics begins enrollment for phase IV trial of Zyflo CR
Read More
Update on Progen's phase III trial design for liver cancer
Read More
Health Canada approves phase I trials of WBI-1001 for psoriasis
Read More
VivaGel trial begins in sexually active young women
Read More
Tercica and Genentech to codevelop Nutropin AQ and Increlex combination drug
Read More
Valeant selects pre-IND candidates for potassium-channel opener program
Read More
Inspire plans phase III trials of epinastine nasal spray for rhinitis
Read More
Peregrine advances study of bavituximab for HCV/HIV coinfection
Read More
Initial enrollment milestone reached in Vical's phase II CMV study
Read More
BioVant shows promise as adjuvant in H5N1 avian flu vaccine
Read More